
Synthetic heptapeptide supplied for in-vitro laboratory characterisation.
Selank 5 mg is not yet released for sale. Batch release, HPLC certification and third-party testing are in progress. Leave your email and we'll notify you the moment it's available.
Selank is a synthetic heptapeptide derived from the sequence of the endogenous tetrapeptide tuftsin, extended with a stabilising tripeptide fragment. It is referenced in in-vitro laboratory literature in the context of peptide characterisation and comparative peptide chemistry.
Every vial supplied by NXT GEN RESEARCH is manufactured to strict laboratory standards, HPLC-characterised and independently third-party tested for identity and purity.
Selank is referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every batch of Selank supplied by NXT GEN RESEARCH is HPLC-characterised and independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Lyophilised material: -20 °C. In solution: 2–8 °C; laboratory practice commonly references a working life of up to 28 days from first entry when stored correctly.
This product is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Mitochondrial-derived peptide supplied for in-vitro laboratory research.

I am over 18 years of age. I am a professional or student researcher.
Research grade compounds · Not for human or animal consumption